Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 10
2017 1
2018 5
2019 19
2020 17
2021 19
2022 17
2023 22
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 34633781

86 results

Results by year

Filters applied: . Clear all
Page 1
Upadacitinib.
[No authors listed] [No authors listed] 2022 Aug 30. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2022 Aug 30. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 34633781 Free Books & Documents. Review.
Upadacitinib tartrate in rheumatoid arthritis.
Stamatis P, Bogdanos DP, Sakkas LI. Stamatis P, et al. Drugs Today (Barc). 2020 Nov;56(11):723-732. doi: 10.1358/dot.2020.56.11.3191007. Drugs Today (Barc). 2020. PMID: 33332480 Clinical Trial.
A review of upadacitinib in rheumatoid arthritis.
Tanaka Y. Tanaka Y. Mod Rheumatol. 2020 Sep;30(5):779-787. doi: 10.1080/14397595.2020.1782049. Epub 2020 Jul 13. Mod Rheumatol. 2020. PMID: 32530345 Free article. Review.
Population Pharmacokinetics of Upadacitinib Using the Immediate-Release and Extended-Release Formulations in Healthy Subjects and Subjects with Rheumatoid Arthritis: Analyses of Phase I-III Clinical Trials.
Klünder B, Mittapalli RK, Mohamed MF, Friedel A, Noertersheuser P, Othman AA. Klünder B, et al. Clin Pharmacokinet. 2019 Aug;58(8):1045-1058. doi: 10.1007/s40262-019-00739-3. Clin Pharmacokinet. 2019. PMID: 30945116 Free PMC article. Clinical Trial.
Upadacitinib for the treatment of rheumatoid arthritis.
Serhal L, Edwards CJ. Serhal L, et al. Expert Rev Clin Immunol. 2019 Jan;15(1):13-25. doi: 10.1080/1744666X.2019.1544892. Epub 2018 Nov 19. Expert Rev Clin Immunol. 2019. PMID: 30394138 Review.
86 results